Novartis Ag (NVS) Non-Current Assets (2016 - 2025)
Historic Non-Current Assets for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $80.5 billion.
- Novartis Ag's Non-Current Assets rose 1095.5% to $80.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $80.5 billion, marking a year-over-year increase of 1095.5%. This contributed to the annual value of $80.5 billion for FY2025, which is 1095.5% up from last year.
- Novartis Ag's Non-Current Assets amounted to $80.5 billion in Q4 2025, which was up 1095.5% from $79.1 billion recorded in Q3 2025.
- Novartis Ag's 5-year Non-Current Assets high stood at $100.2 billion for Q2 2021, and its period low was $67.0 billion during Q3 2023.
- For the 5-year period, Novartis Ag's Non-Current Assets averaged around $80.4 billion, with its median value being $79.6 billion (2023).
- Its Non-Current Assets has fluctuated over the past 5 years, first crashed by 1775.61% in 2023, then soared by 1095.5% in 2025.
- Quarter analysis of 5 years shows Novartis Ag's Non-Current Assets stood at $86.1 billion in 2021, then decreased by 6.43% to $80.5 billion in 2022, then fell by 13.76% to $69.5 billion in 2023, then increased by 4.43% to $72.5 billion in 2024, then grew by 10.96% to $80.5 billion in 2025.
- Its Non-Current Assets was $80.5 billion in Q4 2025, compared to $79.1 billion in Q3 2025 and $78.5 billion in Q2 2025.